Axcelead Drug Discovery Partners Inc.

Axcelead, Inc. (Axcelead株式会社) is a healthcare platform company whose core business is Axcelead Drug Discovery Partners Inc., a drug discovery solution provider. Its drug discovery support business began on July 1, 2017, succeeding Takeda Pharmaceutical Company's drug discovery platform. On April 1, 2019 it became a wholly owned subsidiary of the Sōyaku Ishin Investment Limited Partnership, and on April 1, 2020 it became a holding company through a company split. Its head office is in Minato-ku, Tokyo.

Axcelead, Inc. is a healthcare platform company whose core business is Axcelead Drug Discovery Partners Inc., a drug discovery solution provider. The drug discovery support business began on July 1, 2017, succeeding the drug discovery platform of Takeda Pharmaceutical Company, with Axcelead Drug Discovery Partners commencing operations. On April 1, 2019, it became a wholly owned subsidiary of the Sōyaku Ishin Investment Limited Partnership. On April 1, 2020, it became a holding company through a company split (new establishment split).

A healthcare platform company aiming to be the most trusted innovative healthcare platformer globally, connecting diverse players as the core of the drug discovery ecosystem.

1. 1AXCELEADaxcelead-hd.com
2. 2AXCELEADaxcelead-hd.com
3. 3Axcelead Drug Discovery Partners Inc. (Japan)wikidata.org